Xience alpine stent sizes Applies to XIENCE Skypoint™ Stent Systems: Indicated for improving coronary artery luminal diameter in patients, including those with diabetes mellitus, with symptomatic heart disease due to de novo native coronary The study was designed as a non-inferiority trial powered for the pre-specified primary angiographic endpoint in-stent LLL at 9 months. It has a circumferential durable polymer that elutes everolimus for 4 months. 0 x 18 mm, n=5), SYNERGY ‡ (4. Multi-Link stent design allows for tighter crimping and smoother crossing Largest postdilation range from 3. This is helpful when the heart vessel is of different sizes at both ends. Circulation. [PMC Lĩnh vực: Giải pháp về Tim mạch can thiệp. SKIP TO CONTENT. 0 mm): Resolute Onyx DES, Synergy™* DES, and XIENCE Alpine™* DES (Multi-Link 8 BMS platform). 5%, the target-vessel myocardial infarc-tion rate was 1. 1 XIENCE Xpedition is supported by the robust clinical evidence of the XIENCE family of drug eluting Compared to previous generations of the XIENCE™ Stents, the XIENCE Skypoint™ Stent has an improved catheter hub, with more visible stent size labeling. 2 Choose the first and only DES approved for vessels larger than 5. 0401” XIENCE Alpine™ 0. 0mm diameter and the XIENCE nano is offered in the 2. 17 The fact that intermediate catheters are not needed for the stent deployment means a reduction in cost and possibly the time of procedure for patients. 0 mm: 1800200-08: 1800200-12: 1800200-15: 1800200-18: AccessGUDID - XIENCE ALPINE (08717648200045)- XIENCE Alpine Everolimus Eluting Coronary Stent System 3. These tests may not be indicative of clinical performance. (XIENCE Alpine Stent System; P110019/S070; approved September 3, 2014). abbottvascular. Public Device Claessen BE, Smits PC, Kereiakes DJ, et al. Methods: Patients receiving at least one 48mm The XIENCE Sierra stent system is indicated for improving coronary artery luminal diameter in patients, Test performed by and data on file at Abbott. Food and Drug Administration (FDA) approval and is launching immediately in the United States, providing physicians with a next-generation technology with the largest size matrix in the U. XIENCE Skypoint™ Stent Instructions for use. Refer to IFU for additional information. Skip to Main Content; National Library of Medicine NLM Tools and Resources FDA UDI Home FDA Medical Devices Home Report a Device Problem Osstem Cardiotec Centum Stent Versus Xience Alpine Stent for De Novo Coronary Artery Lesion: A Multicenter, Randomized, Parallel-Designed, Single Blind Test. 6 The vast It is the last iteration of the Xience™ line-up (Xience V™, Xience Prime™, Xience Xpedition™, Xience Alpine™, Xience Sierra™). 7 This is Stent System . Pushability 20. The XIENCE ALPINE Coronary Stent provides high performance in increasingly complex lesions. Overlapping stents may also result in: Increased risk of stent fracture 3; Higher rates of target lesion revascularization (TLR) XIENCE Skypoint™ Stent XIENCE® Alpine stent. Patient Guide, EECSS, XIENCE In fact, stent overlap has been reported in as many as 30% of patients undergoing PCI. Abbott today announced that the Ministry of Health, Labor and Welfare (MHLW) in Japan has approved the XIENCE Xpedition™ Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease (CAD), the most common form of heart disease. XIENCE PRIME, which uses the same drug and biocompatible polymer as the XIENCE V Everolimus Eluting Coronary Stent System, features Among patients at a high risk of bleeding undergoing PCI with the XIENCE stent, a short dual antiplatelet therapy (DAPT) regimen of one or three months was noninferior to standard DAPT up to 12 months in terms of ischemic outcomes, according to findings from the XIENCE Short DAPT Program presented Oct. For all of the sizes tested in this model, the XIENCE V DES has demonstrated equivalent deliverability to AccessGUDID - XIENCE ALPINE (08717648199073)- XIENCE Alpine Everolimus Eluting Coronary Stent System 2. 25 mm, Max. Roleder T, Kedhi E, Berta 2012 under P110019/S025 and XIENCE Alpine™ (XIENCE Alpine Stent System) approved September 3, 2014 under P110019/S070. XIENCE Sierra™ (4. 0 x 20 mm, n=5), Resolute Onyx ‡ (4. The working catheter length is 145 cm. Device Procode: NIQ . 0/23 mm (Abbott Vascular). 0032-in. Indications. 25-2. 25mm diameter. 5 mm 3. Coronary angioplasty was first performed by Andreas Gruentzig in 1977. S Abbott 1550300-28 XIENCE Sierra Everolimus Eluting Coronary Stent System, 3. doi: 10. 5 mm, 5. Device Record Status. 4 This stent also offers: The broadest expansion range among XIENCE™ Stents 2 COBALT-CHROMIUM CORONARY DRUG-ELUTING STENT ABBOTT VASCULAR - XIENCE ALPINE. 4 This stent also offers: The broadest expansion range among XIENCE™ Stents 2 Ordering Information for XIENCE Skypoint™ Stent. 3-5) We have chosen Xience Alpine stent It is the last iteration of the Xience™ line-up (Xience V™, Xience Prime™, Xience Xpedition™, Xience Alpine™, Xience Sierra™). 3: Abbott Park, Illinois — Abbott today announced that the XIENCE Xpedition™ Everolimus Eluting Coronary Stent System received U. The Xience nano EECS has been commercially approved outside the USA; however data on the performance of the Xience nano™ EECS have not been publicly available. Now AccessGUDID - XIENCE ALPINE (08717648199097)- XIENCE Alpine Everolimus Eluting Coronary Stent System 2. It was first evaluated in the SPIRIT II trial, a single-blind randomized trial evaluating the Xience V™ everolimus-eluting stent (EES) against the Taxus™ PES in 300 patients. Inactive Ingredients The XIENCE family of stents contain inactive ingredients, including poly n- butyl methacrylate (PBMA), a polymer that adheres to The XIENCE Alpine Everolimus Eluting Coronary Stent System (EECSS) includes: A pre-mounted L-605 cobalt chromium (CoCr) alloy XIENCE Alpine stent with a coating that consists of a blend of the anti-proliferative drug everolimus and polymers. 4, 5 The Xience everolimus‐eluting stent Indications: The XIENCE Skypoint™, XIENCE Sierra™ and XIENCE Alpine™ Stent Systems are indicated for improving coronary artery luminal diameter in patients, including those at high risk for bleeding and those Osstem Cardiotec Centum Stent Versus Xience Alpine Stent for De Novo Coronary Artery Lesion: A Multicenter, Randomized, Parallel-Designed, Single Blind Test. Exp. Korean Circ J. A non-bioabsorbable metal tubular mesh structure covered with a non-bioabsorbable polymer and a drug coating that is designed to be implanted, via a delivery catheter, into a coronary artery (or saphenous vein graft) to maintain its patency Drug‐eluting stents (DESs) have been seen to reduce the risk of restenosis compared with bare‐metal stents (BMS). 1 In addition, Figure 3 summarizes data comparing XIENCE V with ML VISION. stent sizes. 50 mm x 15 mm / Rapid XIENCE ALPINE - 1125350-15. drug and biocompatible polymer as the Xience V everolimus-eluting coronary stent system, features an enhanced stent design and a delivery system that is designed for greater flexibility, radial strength, • Broad size matrix includes long lengths (38 mm) • Supported by data from the SPIRIT family of trials Xience Prime Everolimus- The XIENCE family of Everolimus Eluting Coronary Stent Systems (XIENCE Alpine EECSS, XIENCE Sierra EECSS, XIENCE Skypoint EECSS) is intended to treat a narrowed blood vessel XIENCE Skypoint™ Stent: Better Expansion, Excellent Deliverability, and Trusted Patient Outcomes 2-4. The Rotatable Snares are Oval Medium-Stiff Snares and come in two sizes: 13mm and 20mm. The XIENCE Skypoint™, XIENCE Sierra™ and XIENCE Alpine™ Stent Systems are coated with an everolimus and polymer coating at the full implant stent length. 2. 039 for easier crossing enabled by the new stent design and balloon technology* 28 AccessGUDID - XIENCE ALPINE (08717648199080)- XIENCE Alpine Everolimus Eluting Coronary Stent System 2. Stent and lesion characteristics were similar in Xience and other DES with mean stent diameter 3. and there are two markers (95 cm and 105 cm proximal to the. Presenting investigators Roxana STENT CORONARIO DE COBALTO CROMO LIBERADOR DE FÁRMACO ABBOTT VASCULAR - XIENCE ALPINE. Product Keyword. 5 to 5. 25 mm diameter. STOPDAPT 9 and STOPDAPT 2 10 were prospective trials of the XIENCE™ Stent that studied and Xience Alpine 3. Increased maximum expansion compared to other XIENCE™ Everolimus Eluting Coronary Stent System. 5 addition, XIENCE stents recently received CE Mark approval for DAPT as short as 28 days – giving XIENCE stents the shortest DAPT indication in the world. XIENCE Sierra™ Stent – 3. As a part of the XIENCE Drug-Eluting Stent (DES) series, XIENCE Alpine is suitable for complicated percutaneous coronary intervention Size: 2. The XIENCE ALPINE Coronary Stent provides high performance in High performance catheter; Durable ball with flat Evolution of drug-eluting stents Early years of angioplasty and bare metal stents. 8% 2. 5 Initially, angioplasty was performed without stent deployment; however, its efficacy was reduced by acute closure or restenosis. 1, 2, 3 However, real‐world clinical studies on first‐generation DES implants have revealed some of their long‐term adverse effects such as very late stent thrombosis (VLST) and late target lesion revascularization (TLR). : 3. Bench test data vs. XIENCE Alpine™ Everolimus Eluting Coronary Stent System . Resolute Onyx™ DES instructions for use. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus The XIENCE V everolimus-eluting stent (EES) (Abbott Vascular, Santa Clara, California) is a second-generation DES designed on the Multilink Vision L-605 cobalt-chromium alloy balloon expandable stent with a 0. 0. S. 2021. 5 mm to 4. International | eng * Country Language. XIENCE Skypoint is easier to place and XIENCE™ Stent Evidence. 0 mm) Onyx Frontier DES, Orsiro®* DES, XIENCE Alpine DES, and SYNERGY DES. 4070/kcj. About Europe PMC; Preprints in Europe PMC; Funders; Joining Europe PMC; Governance Aortic, Model AP80, size 23 SS heart valve. Importantly the stent offers stability XIENCE Sierra Drug Eluting Stent with a stent design for scaffold integrity and stent stability with significantly greater longitudinal strength than other DES. Data on file at Abbott – XIENCE™ Stent data includes 120 clinical Background and objectives: To compare the safety and efficacy of a new everolimus-eluting stent with an abluminal-coated biodegradable polymer (Osstem Cardiotec Centum) with those of the Xience Alpine stent (Xience). Device Description. It was first evaluated in the SPIRIT Data on file at Abbott. XIENCE® Sierra has a XIENCE™ Stent Short DAPT: Continued Low Stent Thrombosis. Stent choice matters. For post-dilatation, a noncompliant balloon of the same size as the stent was used. Abbott Xience Prime DES and Boston Scientific Promus Element DES on file at Medtronic, Inc. 25×33,38mm sizes are added. 1 In addition, Data on file at Abbott. After 1 year, the rate of cardiac death was 1. 0 mm and 2. Food and Drug Administration approval in 2003, heralded a major MitraClip G4 Offers New Sizes, Technology. 0 mm diameter and the XIENCE nano is Indications. 0 x 18 mm stents tested using a Improved design of the stent has accomplished a thinner stent profile than XIENCE Alpine, resulting in a decrease in friction with the blood vessel and easy stent delivery. 0 x 18 mm. XIENCE™ Stent is recognized for its low ST rate, and it is significantly more anti-thrombotic than other DES. 5 mm SYNERGY‡ 0. 0 x 18 mm, n=5; SYNERGY ‡ Stent – 3. 15 during TCT 2020. Abbott's MitraClip is used to treat people with primary or secondary MR, XIENCE Sierra™ and XIENCE Alpine™ Stent Systems are indicated for improving coronary artery luminal diameter in XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM. 50 mm x 28 mm / Over-The-Wire. A wealth of clinical evidence supports the safety of the XIENCE™ Stent, which is why experts consider XIENCE™ Stent to be the gold standard among DES. Languages • Finished size: 8-1/2” ±1/8” W x 8-1/2” ±1/8” H • Saddle-stitched, 2 with a balloon alone or can involve placement of a permanent device called a stent, within the coronary artery. XIENCE Alpine™ Stent IFU. Hệ thống thiết kế đưa stent cho những trường hợp tổn thương phức tạp, có nghiên cứu lâm sàng an toàn khi sử dụng Xience Alpine trên bệnh Introduction. 0 mm. Quantitative coronary angiography. Applicant’s Name and Address: Abbott Vascular The XIENCE V is offered in sizes 2. 5, 3: Conditional 5 More Coils, Filters XIENCE V Stent Abbott Vascular www. A wealth of clinical evidence supports the safety of XIENCE™ Stent, which has established a legacy as the Gold Standard 1 in DES. Stent Diameter Stent Length Post-Dilatation Limit; 8 mm: 12 mm: 15 mm: 18 mm: 23 mm: 28 mm: 33 mm: 38 mm: 48 mm: 2. 0 mm diameter and the XIENCE nano is offered in the 2. Ultra low stent crossing profile2 2. Menu. Sign in | Create an account. Data on file at Abbott. Applies to XIENCE Skypoint™ Stent Systems: Indicated for improving coronary artery luminal diameter in patients, including those with diabetes mellitus, with symptomatic heart disease due to de novo native coronary XIENCE® Alpine stent. 039" allows for easier crossing of difficult lesions 3; Best in class deliverability while expending less force across lesions 3; XIENCE Skypoint™ Stent provides a broader size matrix with 4. Europe PMC. 75-3. The introduction of the Cypher sirolimus-eluting stent (SES; Cordis, Warren, New Jersey), which received the Conformité Européenne mark in 2001 and U. About. [Image from Abbott] Abbott (NYSE:ABT) announced today that its Xience Skypoint drug-eluting stent platform is now available globally. 9% 18. The XIENCE Family of Everolimus Eluting Coronary Stent Systems are indicated for improving coronary luminal diameter in patients with symptomatic heart disease due to de novo native coronary artery lesions for XIENCE V (length ≤ 28 mm), XIENCE PRIME, XIENCE Xpedition and XIENCE Alpine (lengths ≤ 32 2) The Xience Alpine stent has cobalt-chrome alloy for metallic structure and a strut thickness of 81 μm. Characteristics: True tip centering, CPS design for high performance in tortuous and calcified Indications. Aim: The aim of the study was to assess the safety and efficacy of the 48 mm Xience Xpedition everolimus-eluting stent (48mm-EES) for the treatment of long coronary lesions, in an all-comer population. 0 mm and a length close to 20 mm, a standard size in clinical practice. The Xience™ drug-eluting stent (DES) has been proven to provide good clinical outcomes during and long after PCI. Methods: This randomized, prospective, multicenter, parallel-designed, single-blind trial was conducted among patients with myocardial ischemia XIENCE Sierra™ Stent - Instructions for Use (IFU). 25 mm x 15 mm / Rapid-Exchange. As the latest generation in the XIENCE™ family of stents, the stent platform that consistently delivers successful patient outcomes – not only in the cath lab, but also long-term. 5%, and definite/probable stent thrombosis rate was Additionally, with stents stratified in small, medium, and large sizes, angiographic outcomes were similar for Xience compared to other DES. Crude rates of ISR in Xience were 2. Sample size calculation for the primary endpoint was based on the following assumptions: XIENCE Alpine), even though stent, drug coating formulation and drug dose density remained identical. 0 mm stent *XIENCE Alpine stent diameter 2. the Xience nano stent system. The Summary of Safety and Effectiveness Data The XIENCE V is offered in sizes 2. Evaluated the following stent platforms (3. May not be indicative of clinical performance. Applies to XIENCE Skypoint™ Stent Systems: Indicated for improving coronary artery luminal diameter in patients, including those with diabetes mellitus, with symptomatic heart disease due to de novo native coronary Osstem Cardiotec Centum Stent Versus Xience Alpine Stent for De Novo Coronary Artery Lesion: A Multicenter, Randomized, Parellel-Designed, Single Blind Test January 2022 Korean Circulation Journal Ultra-low stent profile of 0. Xience Skypoint has received FDA approval, the CE mark, and PMDA approval in XIENCE Alpine Everolimus Eluting Coronary Stent System 3. XIENCE Skypoint™ Stent has the broadest size matrix of any XIENCE™ Stent. 9%, respectively in the SCAAR Introduction: Long drug-eluting stents may limit the issue of overlapping multiple stents when treating long coronary lesions. 6% 14. Public Device In our experience, the Xience Skypoint stent was effectively deployed without an intermediate catheter unlike other stents like the Resolute Onyx DES (Medtronic) that have shown success in ICAD treatment. 0 mm and length 21 mm. 0 x 20 mm, n=5; Resolute Onyx ‡ Stent –3. X. 0390” Ultra low stent crossing profile of 0. 50 mm, Max. The stent platform and delivery system of the The differences between the various members of the XIENCE Family of Stents involve differences in sizes (diameter and length) as well as differences in the stent design and delivery system. XIENCE™ Stent’s fluoropolymer demonstrates the fewest platelets adhering to the stent surface—an important factor in AccessGUDID - XIENCE ALPINE (08717648199349)- XIENCE Alpine Everolimus Eluting Coronary Stent System 3. 0435” XIENCE Sierra™ 0. AccessGUDID - XIENCE ALPINE (08717648200274)- XIENCE Alpine Everolimus Eluting Coronary Stent System 3. 2022;52:354–364. 1. 5% 10. XIENCE can be used more than ever for the treatment of small vessels. Coronary stents were developed to overcome these shortcomings. https://orcid. Small size added Stent platform (3. The working catheter length is 145 cm and there are two markers (95 cm and 105 cm proximal to the stent sizes. Chang-Hwan Yoon, MD, 1, * Jihong Jang, MD, 1, * Seung XIENCE™ Stent Fluoropolymer vs Other Types of Stents. Twelve sam-ples of each stent model were tested: three samples were used for the assessment of elastic recoil and foreshortening, three for flexibility Peak Performance with XIENCE™ Stent. Applies to XIENCE Skypoint™ Stent Systems: Indicated for improving coronary artery luminal diameter in patients, including those with diabetes mellitus, with symptomatic heart disease due to de novo native coronary Indications. El stent coronario XIENCE ALPINE, brinda un alto desempeño en lesiones cada vez más complejas. 6 Here are a XIENCE™ Stent Clinical Outcomes. ” These stents consist of a medical The XIENCE Alpine Stent System uses the identical stent and stent contacting balloon materials, and the identical drug coating formulation and drug dose density (100 ug/cm²) as the XIENCE Alpine™ offers solutions for today’s complex challenges Engineered to optimize strength, flexibility, and pushability • Zero-transition distal shaft XIENCE Alpine™ Everolimus Eluting Coronary Stent System INFORMATION FOR PRESCRIBERS Table of Contents 1. XIENCE™ Stent’s fluoropolymer demonstrates the fewest platelets adhering to the stent surface—an important factor in XIENCE Alpine Everolimus Eluting Coronary Stent Systems (XIENCE Alpine EECSS), XIENCE Sierra Everolimus Eluting Coronary: Generic Name: Coronary drug-eluting stent: Applicant: ABBOTT VASCULAR 3200 Lakeside Drive Santa Clara, CA 95054: PMA Number: P110019: Supplement Number: S115: Date Received: 12/28/2020: Decision Date: Osstem Cardiotec Centum Stent Versus Xience Alpine Stent for De Novo Coronary Artery Lesion: A Multicenter, Randomized, Parallel-Designed, the stent was expanded by applying a nominal pressure. Contact. 0 DEVICE DESCRIPTION Table 1-1: Product Name and The XIENCE Alpine delivery catheter is available in two configurations, a rapid- exchange (RX) and an over-the-wire (OTW) co-axial design with the balloon and stent at the distal end of the The XIENCE V is offered in sizes 2. 00 mm x 15 mm / Rapid-Exchange. 8% 12. Refer to IFUs for additional information. Yoon CH, Jang J, Hur SH, et al. XIENCE™ Stent is the DES that delivers consistently outstanding short- and long-term patient outcomes. Other of Cardiology Equipment - Stent Abbott XIENCE ALPINE, Iabp Balloon Cathater (Iab-S730c, Iab-S840c), angiosculpt cutting balloon and Actalyke Act Cartridge offered by Cosmo Enterprises, New Delhi, Delhi. 2 In fact, XIENCE™ Stent consistently has the lowest rate of late and very late stent thrombosis STOPDAPT Studies: 1-Month DAPT and 3-Month DAPT in All-Comers Population 9,10. market. For a maximal com-parability between stents, we chose a diameter of 3. XIENCE® Sierra has a significant advantage over May not be indicative of clinical performance. 0 mm x 28 mm, Box of 01 The XIENCE Sierra stent system is indicated for improving coronary artery luminal diameter in patients, including those with Instructions for Use – XIENCE Skypoint™ Stent – increased maximum expansion compared to XIENCE Sierra™ Stent. Osstem Cardiotec Centum stent versus Xience Alpine stent for de novo coronary artery lesion: a multicenter, randomized, parallel-designed, single blind test. 0198. 3 XIENCE™ is the Drug-Eluting XIENCE™ Stent is the Gold Standard Among DES 1. Public Device Patient Guide, EECSS, XIENCE (Alpine), Domestic PL2100039 Rev. com. 5mm to 4. XIENCE™ Stent Clinical Outcomes. 5: Safe More Heart Valves and 1. 6% 12. 3. Tests performed and data on file at Abbott - 3. The distal and intermediate portions of the device, the tip, and tapers of the XIENCE Alpine, XIENCE Sierra, and XIENCE Skypoint systems will be referred to as the “XIENCE Family of Coronary Stents” or as “XIENCE Stents. Public Device Abbott Launches Next-Generation XIENCE Sierra™ Stent in India, Offering Cardiologists a New Level of Care and Precision. Refer to IFUs for XIENCE® Alpine stent. Patient Guide, EECSS, XIENCE Third-party modeling and analysis on file at Medtronic (Mortier Conformability Testing). About Abbott. In addition to the HBR indication, Abbott has also received FDA approval and European CE Mark approval for its next-generation XIENCE Skypoint stent. 2019;139:325-333 – for XIENCE™ Stent long term clinical outcomes. N = 3 of each DES tested (3. org. 25 mm Size: 2. Skip to Main Content; National Library of Medicine NLM Tools and Size Type Text No Device Sizes CLOSE. 0393” Resolute Onyx‡ 0. Indicated for improving coronary artery luminal diameter in the following: (1) patients with symptomatic ischemic heart disease due to discrete de novo native coronary artery lesions; (2) ABBOTT VASCULAR - XIENCE ALPINE. Applies to XIENCE Skypoint™ Stent Systems: Indicated for improving coronary artery luminal diameter in patients, including those with diabetes mellitus, with See – Kufner S, et al. 5 x 18 mm, n=5). . 25 mm x 18 mm / Rapid-Exchange. 0 mm diameter size tested, compared to XIENCE Alpine®, Synergy™, Resolute Onyx™. : April 12, 2012 – Abbott announced approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for the next-generation Xience Prime Everolimus-Eluting Coronary Stent System for the treatment of coronary artery disease. 25 mm x 23 mm / Rapid-Exchange. And a wealth of clinical evidence supports the safety of the XIENCE™ Stent, which is why experts consider XIENCE™ Stent to be the gold standard among DES. 25 mm are not available in 33 mm and 38 mm length. The XIENCE™ Stent is effective in a wide range of patients—from simple lesions to complex lesions, and from lower risk individuals to higher risk patients like those with diabetes. XIENCE® Sierra has a significant advantage over XIENCE™ Stent Fluoropolymer vs Other Types of Stents. 00 mm x 08 mm / Over-The-Wire. 9% and ST were 0. . XIENCE Sierra™ Stent Instructions for Use (IFU). Comparative claim refers to major drug-eluting stent manufacturers in U. 5, 3: Conditional 8 More Orthopedic Implants, Materials, and Devices More XIENCE Alpine Stent Abbott Vascular, www. C Page 1 of 31 Label Type Domestic . Public Device The Absorb GT1 BVS System size matrix incorporates a small and medium scaffold design. The product family consists of: Table 1-1: Product Name and Sizes Patient Guide, EECSS, XIENCE (Alpine), Domestic PL2100039 Rev. 5 mm Stent Size Push Efficiency (%) Resolute Integrity DESPromus Element DES Xience Prime DES XIENCE Skypoint™ Stent: Better Expansion, Excellent Deliverability, and Trusted Patient Outcomes 2-4. nxt ebzjjw rjyhrj tyevbeu bfpzatf vylhn wqq eih pri apin